Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

被引：5

作者：

Shah, Nirali N. ^{[1
]}

Azzi, Jacques ^{[2
]}

Cooper, Brenda W. ^{[3
]}

Deol, Abhinav ^{[4
]}

DiPersio, John ^{[5
]}

Koura, Divya ^{[6
]}

McClune, Brian ^{[7
]}

Muffly, Lori S. ^{[8
]}

Mushtaq, Muhammad Umair ^{[9
]}

Narayan, Rupa ^{[10
]}

Suh, Hyung Chan ^{[11
]}

Yanik, Gregory ^{[12
]}

Nath, Sritama ^{[13
]}

Whangbo, Jennifer ^{[13
]}

Koehne, Guenther ^{[14
]}

机构：

[1] Natl Inst Hlth, Pediat Oncol Branch, Bethesda, MD USA

[2] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol Cellular Therapy & Bone M, Tisch Canc Inst, New York, NY USA

[3] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA

[4] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA

[5] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO USA

[6] UCSD Moores Canc Ctr, La Jolla, CA USA

[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[8] Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USA

[9] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Med Ctr, Westwood, KS USA

[10] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA

[11] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[12] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[13] Vor Biopharma, Cambridge, MA USA

[14] Miami Canc Inst, Baptist Hlth South Florida, Miami, FL USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180990

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] CD19 chimeric antigen receptor-T cells as bridging therapy to allogeneic hematopoietic cell transplantation improves outcome in patients with refractory/relapsed B-cell acute lymphoblastic leukemia
Liu, Jie
Xu, Mengyuan
Zhang, Xiaoqian
Zhang, Zhuo
Zhong, Tao
Yu, Hongjuan
Fu, Yueyue
Meng, Hongbin
Feng, Jiawei
Zou, Xindi
Han, Xueying
Kang, Liqing
Yu, Lei
Li, Limin
HELIYON, 2024, 10 (13)
[32] Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia
Lapusan, Simona
Vidriales, Maria B.
Thomas, Xavier
de Botton, Stephane
Vekhoff, Anne
Tang, Ruoping
Dumontet, Charles
Morariu-Zamfir, Rodica
Lambert, John M.
Ozoux, Marie-Laure
Poncelet, Philippe
San Miguel, Jesus F.
Legrand, Ollivier
DeAngelo, Daniel J.
Giles, Francis J.
Marie, Jean-Pierre
INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1121 - 1131
[33] Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation
Hua, Jingsheng
Zhang, Jian
Wu, Xiaoxia
Zhou, Lili
Bao, Xiebing
Han, Yue
Miao, Miao
Li, Caixia
Fu, Zhengzheng
Wu, Depei
Qian, Weiqing
Qiu, Huiying
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (09): : 610 - 616
[34] Specific Targeting of Acute Myeloid Leukemia By the Use of Non-Virally Engineered CIK (Cytokine-Induced Killer) Cells Expressing the Anti-CD33 Chimeric Antigen Receptor (CAR)
Rotiroti, Maria Caterina
Arcangeli, Silvia
Buracchi, Chiara
Magnani, Chiara Francesca
Cappuzzello, Claudia
Biagi, Ettore
Tettamanti, Sarah
Biondi, Andrea
BLOOD, 2018, 132
[35] Phase I study of donor-derived CD5 CAR T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukemia.
Pan, Jing
Tan, Yue
Shan, Lingling
Deng, Biping
Ling, Zhuojun
Song, Weiliang
Feng, Xiaoming
Hu, Guang
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[36] Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia
Zhang, Hui
Wang, Pengfei
Li, Zhuoyan
He, Yingyi
Gan, Wenting
Jiang, Hua
CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3549 - 3555
[37] Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trial
Luo, Yi
Gao, Lei
Liu, Jia
Yang, Luxin
Wang, Lu
Lai, Xiaoyu
Gao, Shichun
Liu, Lizhen
Zhao, Lu
Ye, Yishan
Wang, Manning
Shen, Lianjun
Cao, W. William
Wang, Dongrui
Li, Wenling
Zhang, Xi
Huang, He
ECLINICALMEDICINE, 2024, 67
[38] Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR
Blanka Robesova
Marie Drncova
Adam Folta
Marta Krejci
Frantisek Folber
Zuzana Sustkova
Jiri Mayer
Ivana Jeziskova
Bone Marrow Transplantation, 2020, 55 : 1021 - 1022
[39] Direct Comparison of Anti-CD33 and Anti-CD123 Chimeric Antigen Receptor T Cells with CD28 or 41BB Co-Stimulatory Domains for Treatment of Acute Myeloid Leukemia
Tarun, Samiksha
Qin, Haiying
Yang, Lila
Chien, Christopher Daniel
Kohler, Mark Eric
Fry, Terry J.
BLOOD, 2017, 130
[40] Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR
Robesova, Blanka
Drncova, Marie
Folta, Adam
Krejci, Marta
Folber, Frantisek
Sustkova, Zuzana
Mayer, Jiri
Jeziskova, Ivana
BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1021 - 1022

← 1 2 3 4 5 →